RYR1-Related Myopathies Involve More than Calcium Dysregulation: Insights from Transcriptomic Profiling

Ryanodine receptor 1-related myopathies (RYR1-RM) are caused by <i>RYR1</i> gene variants and comprise a wide spectrum of histopathological manifestations. Here, we focus on patients carrying <i>RYR1</i> variants and muscle histopathology consistent with central core disease (CCD) or multi-minicore disease (MmD). RNA-sequencing analyses of skeletal muscle biopsies obtained from both CCD and MmD patients and from healthy controls were performed to better understand the molecular pathways activated by <i>RYR1</i> variants. Our analyses revealed that, beyond the well-established role of RYR1 in calcium homeostasis, broader cellular pathways are implicated. In CCD, differentially expressed genes were enriched for pathways related to oxidative stress response, SMAD signalling, and apoptosis, consistent with the role of intracellular calcium dysregulation in promoting mitochondrial dysfunction and cell death. In contrast, MmD patients exhibited enrichment of pathways related to immune activation. This was corroborated by the upregulation of GTPase-regulating genes and the down-regulation of transcriptional repressors such as <i>ZFP36</i> and <i>ATN1.</i> When considering all RYR1-RM patients collectively, Wnt signalling, immune-related pathways, and oxidative phosphorylation emerged as shared enriched pathways, indicating possible convergent mechanisms across histopathological phenotypes. Our study suggests that complex gene regulation driven by <i>RYR1</i> variants may be a unifying feature in CCD and MmD, offering new insight into potential therapeutic targets.